| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 1.20T | 1.14T | 967.76B | 903.92B | 763.84B | 1.04T |
| Gross Profit | 87.14B | 79.80B | 78.21B | 70.52B | 64.14B | 81.85B |
| EBITDA | 34.04B | 38.08B | 17.23B | 31.77B | 28.68B | 40.31B |
| Net Income | 28.87B | 24.75B | 4.28B | 19.06B | 16.99B | 25.71B |
Balance Sheet | ||||||
| Total Assets | 420.31B | 440.12B | 405.26B | 406.69B | 356.20B | 383.76B |
| Cash, Cash Equivalents and Short-Term Investments | 19.12B | 55.42B | 69.37B | 52.12B | 46.96B | 32.06B |
| Total Debt | 20.70B | 21.53B | 21.87B | 27.22B | 28.73B | 28.78B |
| Total Liabilities | 265.69B | 287.81B | 263.12B | 262.72B | 220.03B | 254.43B |
| Stockholders Equity | 154.62B | 152.09B | 141.93B | 143.00B | 135.26B | 128.29B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 3.98B | 22.53B | 15.30B | 25.45B | 6.67B |
| Operating Cash Flow | 0.00 | 5.91B | 24.54B | 16.96B | 28.16B | 9.43B |
| Investing Cash Flow | 0.00 | -2.59B | -4.95B | -1.63B | -2.93B | -1.36B |
| Financing Cash Flow | 0.00 | -17.40B | -2.86B | -10.34B | -10.72B | -7.59B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
81 Outperform | ¥185.59B | 4.98 | 17.09% | 2.94% | 9.67% | 45.58% | |
76 Outperform | ¥256.44B | 10.08 | ― | 3.08% | 22.81% | 504.99% | |
75 Outperform | ¥98.24B | 14.91 | ― | 2.72% | -0.41% | -10.32% | |
74 Outperform | ¥49.00B | 13.51 | ― | 4.12% | -4.88% | -26.05% | |
65 Neutral | ¥29.53B | -17.27 | ― | 5.16% | 1.71% | -29.37% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
58 Neutral | ¥32.58B | 40.99 | 1.55% | 1.34% | -34.13% | -31.24% |